CCTA is safe and effective, and saves time when assessing patients at low- to intermediate-risk of a heart attack.
Coronary CT angiography (CCTA) in the emergency department is safe and effective, and saves time when assessing patients at low- to intermediate-risk of a heart attack, according to a study published online in the New England Journal of Medicine and presented at the American College of Cardiology 61st Annual Scientific Session.
Researchers from the Perelman School of Medicine at the University of Pennsylvania undertook the large, multicenter American College of Radiology Imaging Network (ACRIN) trial to confirm that CCTA was safe to use in patients with suspected heart attacks, allowing ED physicians the confidence to triage low- to intermediate-risk patients according to the scan’s results.
“Prior research, including work by our research team at Penn, established that CCTA can rapidly identify the extent of coronary artery disease, if present, and suggested the safety of CCTA for clinical decision making,” said Harold I. Litt, MD, PhD, chief of cardiovascular imaging in the Department of Radiology at the university.
RELATED: Early CT Angiography Identifies Recurrent Stroke Risk
The study included 908 low- to intermediate-risk patients with chest pain, who were assigned to the CCTA rapid rule-out strategy group, and 462 who were treated traditionally. Patients from both groups whose testing showed heart muscle injury were admitted to the hospital and those with negative tests were discharged. Patients who had negative tests were called 30 days after enrollment for follow up. No deaths within 30 days of discharge were reported among the 640 patients who had negative CCTA results.
“The trial results have significant potential to establish a new standard of care for low- to intermediate-risk patients, dramatically reduce health care utilization and lower medical costs,” said Judd Hollander, MD, co-principal investigator and clinical research director in the Department of Emergency Medicine at the University of Pennsylvania. “In addition to identifying the patients who could safely be discharged, the trial results showed evaluation with CCTA compared with current practice led to fewer patients having cardiac catheterizations that were found to be unnecessary and identified more patients that truly required hospital care.”
There will be more information available from this trial. “The trial’s secondary aims of comparing health care utilization of the two arms and their respective patient outcomes at one-year follow-up will also be important data to report, given the increasing scrutiny of health-care delivery costs,” said Pamela K. Woodard, MD, head of advanced imaging at Washington University School of Medicine and chair of ACRIN’s Cardiovascular Committee.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.